On the Cutting Edge of Cardiovascular Discovery – Learnings from ACC 2025 and Future Perspectives
April 9, 2025 from 10:30 AM – 11:30 AM EDT
Join this webinar for the latest insights in cardiovascular discovery and key takeaways from ACC 2025.
0
days leftAbout this webinar
Our panel of leading experts will share insights from ACC 2025, including highlights from Late-Breaking Clinical Trials (LBCT) Reverse-It, Stride, and FAIR-HF2. The panel will also discuss other significant presentations, diving deep into topics such as lipids (Lp(a), ANGPTL3, Oral PCSK9i), the Soul trial, and the Summit and CardiAmp-HF studies. Attendees will gain a comprehensive understanding of the current state of cardiovascular research and explore future directions, including the role of GLP1 agonists in heart failure, emerging lipid management strategies, and the potential of GLP1 and other therapies in vascular disease.
The panel will feature Dr. Stefan Anker (Charité University Medicine), Dr. Deepak Bhatt (Mount Sinai Health System), and Dr. Marc Bonaca (University of Colorado School of Medicine), and will be moderated by Rafal Ziecina of Worldwide Clinical Trials.
Date & Time
Wednesday April 9, 2025 from 10:30 AM – 11:30 AM EDT
Rafal Ziecina, MD, PhD
Executive Director, Scientific Solutions, Cardiovascular, Endocrine & Metabolic
Rafal Ziecina, MD, PhD, Executive Director of Scientific Solutions at Worldwide Clinical Trials, has built his expertise over more than two decades working in pharmaceutical companies and research organizations. At Worldwide Clinical Trials, he provides scientific and medical leadership of cardiovascular and metabolic research initiatives. For sponsors, Dr. Ziecina provides strategic service around filing, regulatory, and safety, as well as writing services for protocol and drug development plans.
